No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
KIDS240719C40000
- 1.05
- 0.000.00%
15min DelayClose Jul 5 15:58 ET
0.00High0.00Low
1.05Open1.05Pre Close0 Volume66 Open Interest40.00Strike Price0.00Turnover151.82%IV33.24%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier13DDays to Expiry1.05Extrinsic Value100Contract SizeAmericanOptions Type0.2297Delta0.0337Gamma29.34Leverage Ratio-0.1022Theta0.0022Rho6.74Eff Leverage0.0180Vega
Intraday
- 5D
- Daily
News
Does OrthoPediatrics (NASDAQ:KIDS) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
JMP Securities Maintains OrthoPediatrics(KIDS.US) With Buy Rating, Maintains Target Price $50
JMP Securities analyst David Turkaly maintains $OrthoPediatrics(KIDS.US)$ with a buy rating, and maintains the target price at $50.According to TipRanks data, the analyst has a success rate of 39.9% a
OrthoPediatrics Insiders Sold US$768k Of Shares Suggesting Hesitancy
OrthoPediatrics Corp. (NASDAQ:KIDS) shareholders might have a reason to worry after multiple insiders sold their shares over the last year. When evaluating insider transactions, knowing whether insi
OrthoPediatrics Corp. to Participate in the Truist Securities MedTech Conference
WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced
OrthoPediatrics Poised for Robust Growth With Strategic Acquisitions and Market Positioning: A Strong Buy Recommendation
OrthoPediatrics Corp Enhances Transparency With Investor Presentations
Comments
Despite revenue growth, the share price drop may signal unresolved issues. The company's performance, worse than the 5% annualised loss over the last half decade, could be a bad omen. Contrarian investors might see a potential turnaround.
OrthoPediatrics (NASDAQ:KIDS Shareholders Incur Further Losses as Stock Declines 8.6% This Week, Taking One-year Losses to 44%Insider selling activity might concern shareholders and the lack of insider buying over the past year adds to this worry. Despite some alignment due to insider ownership, the history of sales necessitates caution before buying company shares.
The partnership with Ora Medical strengthens OrthoPediatric's non-surgical offerings, enhancing their mobility solutions portfolio. Ora views it as a key step in expanding beyond Canada, supported by OrthoPediatrics' market presence and expertise.
Read more